Molbio Diagnostics Raises Rs 281 Crore from Anchor Investors Ahead of IPO
Molbio Diagnostics Ltd, backed by Temasek and Motilal Oswal Private Equity, raised Rs 281.5 crore from 33 anchor investors ahead of its IPO priced at Rs 768-807 per share. The IPO, opening August 10 and closing August 12, aims to raise Rs 904-940 crore through a fresh issue and offer for sale by existing shareholders. Funds will support infrastructure, R&D facilities, and equipment upgrades. Major anchor investors include Goldman Sachs, BlackRock, and several mutual funds. Shares will debut on August 17.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (58/100). Lens Score 53/100.
Outlets measured: economictimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 8 Aug, 03:15 am. Other outlets followed.
- 1